Takatoshi Shimauchi

28PUBLICATIONS
57CO-AUTHORS
Medical mycologyPredictive and prognostic markersMolecular targetsHaematological tumoursImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Apr 20, 2026
Pustular Mycosis Fungoides Triggered by Systemic Interferon-γ.

|Nov 07, 2025
Japanese Dermatological Association Guidelines: Outlines of Japanese Guidelines for the Management of Primary Cutaneous Lymphomas 2025.

Toshihisa Hamada, Makoto Sugaya, Takashi Sakaida

|Oct 09, 2025
Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphoma.

Takatoshi Shimauchi, Junko Murai, Manami Iwasaki

|Aug 23, 2025
An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients with Adult T-Cell Leukemia/Lymphoma.

Kentaro Yonekura, Ikko Muto, Motoi Takenaka

|Nov 04, 2024
A case of indeterminate cell histiocytosis with ETV3-NCOA2 translocation.

Norihito Suzuki, Takatoshi Shimauchi, Satoshi Baba

|Jun 14, 2024
Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma.

Yoji Hirai, Jun Sakurai, Shiho Yoshida

Pageof 5

Frequent Collaborators

7 joint publications

Taisuke Ito

6 joint publications

Tetsuya Honda

4 joint publications

Tomomitsu Miyagaki

4 joint publications

Taku Fujimura